What is Lifevantage's operating income?

Lifevantage's total operating income in 2025 was $12.20 million, based on the following breakdown: Total Gross Profit: $183.67 million Total Operating Expenses: $171.47 million

Lifevantage (LFVN) Financials

$6.18 -0.02 (-0.32%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$6.18 0.00 (0.00%)

As of 07/16/2026 07:04 PM Eastern

Compare

Annual Income Statements for Lifevantage

This table shows Lifevantage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	7.13	6.11	1.61	5.76	7.43	12	13	3.12	2.54	2.94	9.81
Consolidated Net Income / (Loss)	7.13	6.11	1.61	5.76	7.43	12	13	3.12	2.54	2.94	9.81
Net Income / (Loss) Continuing Operations	7.13	6.11	1.61	5.76	7.43	12	13	3.12	2.54	2.94	9.81
Total Pre-Tax Income	11	8.68	2.91	9.55	9.23	15	17	4.69	4.00	4.35	12
Total Operating Income	14	13	4.45	10	9.81	15	18	7.58	4.26	4.33	12
Total Gross Profit	162	173	166	168	188	195	182	168	170	159	184
Total Revenue	190	207	199	203	226	233	220	206	213	200	229
Operating Revenue	190	207	199	203	226	233	220	206	213	200	229
Total Cost of Revenue	28	34	33	35	38	38	38	38	43	41	45
Operating Cost of Revenue	28	34	33	35	38	38	38	38	43	41	45
Total Operating Expenses	148	159	162	158	178	179	164	161	166	154	171
Selling, General & Admin Expense	57	56	65	60	70	68	61	63	71	68	69
Other Operating Expenses / (Income)	91	103	97	98	109	112	104	97	95	86	102
Total Other Income / (Expense), net	-3.25	-4.73	-1.54	-0.78	-0.58	-0.81	-0.38	-2.88	-0.26	0.02	0.04
Interest Expense	3.09	3.32	0.57	0.46	0.32	0.12	0.02	0.01	-0.20	-0.43	-0.43
Other Income / (Expense), net	-0.16	-1.41	-0.97	-0.32	-0.26	-0.69	-0.37	-0.67	-0.46	-0.41	-0.39
Income Tax Expense	3.53	2.58	1.30	3.79	1.80	3.11	4.34	1.57	1.46	1.41	2.44
Basic Earnings per Share	$0.51	$0.44	$0.12	$0.41	$0.53	$0.82	$0.92	$0.24	$0.20	$0.24	$0.80
Weighted Average Basic Shares Outstanding	13.90M	13.73M	13.88M	13.99M	14.06M	14.11M	14.07M	12.89M	12.56M	12.46M	12.25M
Diluted Earnings per Share	$0.50	$0.42	$0.11	$0.41	$0.50	$0.79	$0.90	$0.24	$0.20	$0.23	$0.75
Weighted Average Diluted Shares Outstanding	14.15M	14.53M	13.40M	14.14M	14.12M	14.60M	14.27M	13.07M	12.57M	12.99M	12.99M
Weighted Average Basic & Diluted Shares Outstanding	14.15M	14.53M	13.40M	14.14M	14.12M	14.35M	13.65M	12.55M	12.70M	12.48M	12.69M
Cash Dividends to Common per Share	-	-	-	-	-	-	-	$0.03	$0.13	$0.55	$0.17

This table shows Lifevantage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	0.63	-0.66	1.66	1.31	1.83	2.55	3.47	1.96	2.16	0.28	1.36
Consolidated Net Income / (Loss)	0.63	-0.66	1.66	1.31	1.83	2.55	3.47	1.96	2.16	0.28	1.36
Net Income / (Loss) Continuing Operations	0.63	-0.66	1.66	1.31	1.83	2.55	3.47	1.96	2.16	0.28	1.36
Total Pre-Tax Income	0.83	-1.11	1.92	2.71	2.58	3.09	4.18	2.40	2.24	0.47	1.66
Total Operating Income	0.75	-1.26	1.93	2.91	2.57	3.43	4.05	2.15	2.27	0.49	1.68
Total Gross Profit	41	41	38	39	38	55	47	44	38	36	35
Total Revenue	51	52	48	49	47	68	58	55	48	49	44
Operating Revenue	51	52	48	49	47	68	58	55	48	49	44
Total Cost of Revenue	10	11	10	10	9.49	13	11	11	9.75	13	9.17
Operating Cost of Revenue	10	11	10	10	9.49	13	11	11	9.75	13	9.17
Total Operating Expenses	40	42	36	36	35	51	43	42	36	36	33
Selling, General & Admin Expense	18	20	16	14	15	19	17	19	15	16	14
Other Operating Expenses / (Income)	22	22	20	22	20	33	26	23	21	20	19
Total Other Income / (Expense), net	0.08	0.15	-0.01	-0.20	0.01	-0.34	0.13	0.25	-0.03	-0.01	-0.02
Interest & Investment Income	0.17	0.11	0.08	-	0.06	0.13	0.13	-	0.09	0.02	0.02
Other Income / (Expense), net	-0.09	0.04	-0.09	-0.28	-0.05	-0.47	-0.00	0.14	-0.11	-0.03	-0.05
Income Tax Expense	0.20	-0.46	0.26	1.41	0.75	0.54	0.71	0.44	0.09	0.20	0.29
Basic Earnings per Share	$0.05	($0.05)	$0.13	$0.11	$0.15	$0.21	$0.28	$0.16	$0.17	$0.02	$0.11
Weighted Average Basic Shares Outstanding	12.54M	12.61M	12.42M	12.46M	12.16M	12.21M	12.35M	12.25M	12.40M	12.64M	12.63M
Diluted Earnings per Share	$0.05	($0.05)	$0.13	$0.10	$0.14	$0.19	$0.26	$0.16	$0.17	$0.02	$0.11
Weighted Average Diluted Shares Outstanding	13.11M	12.61M	12.99M	12.99M	12.82M	13.18M	13.30M	12.99M	12.95M	12.75M	12.66M
Weighted Average Basic & Diluted Shares Outstanding	12.71M	12.87M	12.70M	12.48M	12.53M	12.55M	12.59M	12.69M	12.70M	12.79M	12.62M
Cash Dividends to Common per Share	$0.44	$0.04	$0.04	-	$0.04	$0.04	$0.04	-	$0.05	$0.05	$0.05

This table details how cash moves in and out of Lifevantage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-6.48	-6.02	3.58	5.11	2.16	3.31	1.04	-2.98	1.42	-4.72	3.32
Net Cash From Operating Activities	13	6.04	6.60	13	18	18	16	7.96	6.83	12	12
Net Cash From Continuing Operating Activities	13	6.05	6.60	13	18	18	16	7.96	6.83	12	12
Net Income / (Loss) Continuing Operations	7.13	6.11	1.61	5.76	7.43	12	13	3.12	2.54	2.94	9.81
Consolidated Net Income / (Loss)	7.13	6.11	1.61	5.76	7.43	12	13	3.12	2.54	2.94	9.81
Depreciation Expense	2.29	1.90	1.64	1.33	1.90	2.78	3.46	3.26	3.58	3.58	3.16
Amortization Expense	0.45	0.42	0.03	0.03	0.04	2.37	2.37	1.79	0.00	0.01	0.03
Non-Cash Adjustments To Reconcile Net Income	1.81	5.37	3.00	3.20	5.53	4.92	2.03	3.89	4.97	4.57	7.14
Changes in Operating Assets and Liabilities, net	1.55	-7.73	0.32	2.94	2.90	-3.29	-4.48	-4.10	-4.26	1.10	-8.25
Net Cash From Investing Activities	-1.16	-0.56	-1.06	-4.65	-4.51	-2.68	-3.73	-1.53	-3.06	-2.25	-1.37
Net Cash From Continuing Investing Activities	-1.16	-0.56	-1.06	-4.65	-4.51	-2.68	-3.73	-1.53	-3.06	-2.25	-1.37
Purchase of Property, Plant & Equipment	-1.16	-0.56	-1.06	-4.65	-2.51	-2.68	-3.74	-1.53	-3.07	-2.25	-1.37
Sale of Property, Plant & Equipment	-	-	-	-	0.00	0.00	0.01	0.00	0.01	0.00	0.00
Net Cash From Financing Activities	-18	-12	-1.96	-3.50	-11	-12	-11	-8.95	-2.36	-14	-7.60
Net Cash From Continuing Financing Activities	-18	-12	-1.96	-3.50	-11	-12	-11	-8.95	-2.36	-14	-7.60
Repayment of Debt	-9.20	-22	-2.00	-2.06	-4.00	-1.50	0.00	-	0.00	-0.10	0.00
Repurchase of Common Equity	-9.85	0.00	0.00	-1.50	-4.66	-5.41	-12	-8.83	-0.82	-6.43	-3.15
Payment of Dividends	-	-	-	-	-	0.00	0.00	-0.38	-1.59	-6.94	-2.07
Issuance of Common Equity	0.47	0.26	0.04	0.06	0.70	0.73	1.90	0.51	0.25	0.27	0.28
Other Financing Activities, net	0.13	0.27	0.00	0.00	-3.17	-6.25	-1.42	-0.25	-0.20	-1.22	-2.66
Effect of Exchange Rate Changes	-0.09	0.20	-	-	-	0.09	-0.05	-0.46	0.00	-0.25	0.40
Cash Interest Paid	2.63	1.34	0.44	0.35	0.23	0.04	0.02	0.01	0.01	0.02	0.00
Cash Income Taxes Paid	1.66	1.37	5.50	2.87	1.29	1.62	4.02	2.60	1.87	2.31	4.92

This table details how cash moves in and out of Lifevantage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-3.20	-1.07	0.05	-0.49	-2.29	7.00	0.87	-2.27	-7.11	-2.91	2.30
Net Cash From Operating Activities	4.77	1.76	3.09	2.58	-0.58	9.20	2.23	1.03	-2.31	2.79	4.99
Net Cash From Continuing Operating Activities	4.77	1.76	3.09	2.58	-0.58	9.20	2.23	1.03	-2.31	2.79	4.99
Net Income / (Loss) Continuing Operations	0.63	-0.66	1.66	1.31	1.83	2.55	3.47	1.96	2.16	0.28	1.36
Consolidated Net Income / (Loss)	0.63	-0.66	1.66	1.31	1.83	2.55	3.47	1.96	2.16	0.28	1.36
Depreciation Expense	0.92	0.96	0.90	0.81	0.80	0.81	0.80	0.75	0.61	0.75	0.71
Amortization Expense	0.22	-0.22	0.92	-0.91	0.36	-0.35	0.01	0.01	0.01	0.70	-0.68
Non-Cash Adjustments To Reconcile Net Income	0.98	1.33	-1.72	2.05	0.91	2.43	1.88	1.91	1.18	4.09	0.51
Changes in Operating Assets and Liabilities, net	2.02	0.34	1.33	-0.66	-4.48	3.76	-3.93	-3.60	-6.25	-3.02	3.09
Net Cash From Investing Activities	-1.13	-0.54	-0.29	-0.28	-0.35	-0.49	-0.33	-0.20	-0.44	-4.83	-1.01
Net Cash From Continuing Investing Activities	-1.13	-0.54	-0.29	-0.28	-0.35	-0.49	-0.33	-0.20	-0.44	-4.83	-1.01
Purchase of Property, Plant & Equipment	-1.13	-0.54	-0.29	-0.28	-0.35	-0.49	-0.33	-0.20	-0.44	-1.08	-1.01
Net Cash From Financing Activities	-6.67	-2.54	-2.46	-2.74	-1.83	-1.40	-1.13	-3.24	-4.30	-0.74	-1.60
Net Cash From Continuing Financing Activities	-6.67	-2.54	-2.46	-2.74	-1.83	-1.40	-1.13	-3.24	-4.30	-0.74	-1.60
Repurchase of Common Equity	-0.80	-1.88	-1.93	-1.83	-1.11	-	-	-2.03	-0.58	0.00	-1.01
Payment of Dividends	-5.53	-0.46	-0.45	-0.50	-0.50	-0.50	-0.50	-0.56	-0.57	-0.58	-0.57
Issuance of Common Equity	0.13	-	0.15	-	0.13	-	0.15	-	0.15	-	0.08
Other Financing Activities, net	-0.47	-0.21	-0.23	-0.31	-0.35	-0.90	-0.77	-0.65	-3.28	-0.16	-0.10
Effect of Exchange Rate Changes	-0.16	0.26	-0.29	-0.05	0.47	-0.31	0.10	0.14	-0.07	-0.14	-0.08
Cash Interest Paid	0.00	0.00	0.00	0.02	0.01	-0.01	-	0.00	0.00	0.01	0.00
Cash Income Taxes Paid	0.17	0.47	0.75	0.93	2.00	0.06	1.52	1.33	0.77	0.10	0.06

This table presents Lifevantage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	40	51	45	51	55	59	79	71	66	60	72
Total Current Assets	30	43	36	39	43	44	48	47	44	38	51
Cash & Equivalents	14	7.88	11	17	19	22	23	20	22	17	20
Accounts Receivable	1.03	1.55	1.33	2.07	2.07	2.61	2.93	3.34	1.61	2.95	3.29
Inventories, net	9.25	25	17	14	14	14	16	16	16	15	21
Prepaid Expenses	3.00	6.30	5.27	6.14	7.31	5.23	4.77	5.21	4.75	2.44	6.10
Current Deferred & Refundable Income Taxes	3.30	2.26	0.91	0.45	1.24	0.00	1.04	1.75	0.24	0.31	0.64
Plant, Property, & Equipment, net	5.76	3.46	3.13	6.59	7.13	7.17	11	9.50	9.09	7.81	6.21
Total Noncurrent Assets	3.55	4.29	6.58	5.62	4.95	7.84	20	14	13	15	15
Goodwill	-	-	-	-	-	-	-	-	-	-	0.00
Intangible Assets	1.88	1.74	1.25	1.12	0.98	0.85	0.72	0.59	0.46	0.32	0.25
Noncurrent Deferred & Refundable Income Taxes	0.24	1.02	4.09	3.26	2.69	2.16	1.21	1.29	2.99	4.27	5.97
Other Noncurrent Operating Assets	1.43	1.52	1.24	1.25	1.28	4.82	18	12	9.31	10	8.64
Total Liabilities & Shareholders' Equity	40	51	45	51	55	59	79	71	66	60	72
Total Liabilities	36	40	31	29	28	26	42	39	31	34	37
Total Current Liabilities	26	31	23	24	26	25	25	26	20	22	27
Accounts Payable	2.61	8.89	4.85	3.81	5.18	3.52	6.74	7.46	3.51	5.85	4.60
Accrued Expenses	12	16	16	18	19	20	15	15	15	14	21
Other Current Liabilities	-	-	-	-	-	1.18	2.15	2.60	1.52	1.81	1.87
Total Noncurrent Liabilities	11	9.58	7.37	5.39	1.88	0.60	17	13	12	12	10
Capital Lease Obligations	-	-	-	-	-	-	16	13	12	12	9.81
Other Noncurrent Operating Liabilities	2.06	2.17	1.93	1.98	1.88	0.60	0.69	0.31	0.30	0.20	0.29
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3.33	11	15	22	27	33	37	32	35	26	35
Total Preferred & Common Equity	3.33	11	15	22	27	33	37	32	35	26	35
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3.33	11	15	22	27	33	37	32	35	26	35
Common Stock	118	119	122	125	127	126	129	131	134	137	140
Retained Earnings	-114	-109	-107	-103	-100	-93	-92	-98	-98	-109	-104
Accumulated Other Comprehensive Income / (Loss)	-0.25	-0.01	-0.09	0.01	0.06	0.14	0.10	-1.12	-1.36	-1.92	-1.18

This table presents Lifevantage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	67	63	61	61	69	77	62	61	62
Total Current Assets	42	39	38	39	46	54	45	39	39
Cash & Equivalents	18	17	17	15	22	22	13	10	12
Accounts Receivable	2.50	2.34	2.14	2.97	2.09	3.24	2.43	2.26	2.42
Inventories, net	16	15	15	17	17	22	21	19	18
Prepaid Expenses	5.14	3.79	2.76	3.45	4.64	6.18	3.64	4.42	3.83
Current Deferred & Refundable Income Taxes	0.15	0.23	0.36	0.89	0.00	0.00	5.30	2.73	2.20
Plant, Property, & Equipment, net	9.31	8.97	8.35	7.48	7.14	6.73	6.00	6.43	6.85
Total Noncurrent Assets	15	15	15	15	16	16	11	16	16
Goodwill	-	-	-	-	-	-	-	0.47	0.47
Intangible Assets	0.42	0.39	0.36	0.29	0.26	0.22	0.25	3.32	3.19
Noncurrent Deferred & Refundable Income Taxes	4.69	4.62	4.93	4.78	5.78	6.89	1.99	4.51	4.81
Other Noncurrent Operating Assets	10	10	9.88	10	9.56	9.28	8.30	7.88	7.50
Total Liabilities & Shareholders' Equity	67	63	61	61	69	77	62	61	62
Total Liabilities	37	35	35	34	39	43	28	28	29
Total Current Liabilities	25	23	22	22	28	33	19	19	20
Accounts Payable	6.76	6.24	6.95	5.27	5.76	7.04	4.36	4.89	5.15
Accrued Expenses	15	14	13	15	19	23	13	12	13
Other Current Liabilities	1.66	1.65	1.68	1.90	1.89	1.93	1.88	1.89	1.89
Total Noncurrent Liabilities	13	12	12	12	11	11	9.59	9.17	8.69
Capital Lease Obligations	12	12	12	11	11	10	9.31	8.80	8.32
Other Noncurrent Operating Liabilities	0.15	0.23	0.21	0.23	0.21	0.22	0.28	0.37	0.37
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	29	27	27	28	30	34	33	33	33
Total Preferred & Common Equity	29	27	27	28	30	34	33	33	33
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	29	27	27	28	30	34	33	33	33
Common Stock	135	135	136	137	138	139	138	138	139
Retained Earnings	-104	-107	-108	-109	-106	-104	-103	-103	-104
Accumulated Other Comprehensive Income / (Loss)	-1.66	-1.19	-1.72	-1.13	-1.81	-1.55	-1.36	-1.61	-1.73

This table displays calculated financial ratios and metrics derived from Lifevantage's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
DEI Shares Outstanding	97,021,189.00	14,008,252.00	14,232,609.00	14,306,851.00	14,340,159.00	14,313,179.00	14,004,850.00	12,590,098.00	12,794,719.00	-	12,588,183.00
DEI Adjusted Shares Outstanding	13,860,170.00	14,008,252.00	14,232,609.00	14,306,851.00	14,340,159.00	14,313,179.00	14,004,850.00	12,590,098.00	12,794,719.00	-	12,588,183.00
DEI Earnings Per Adjusted Shares Outstanding	0.51	0.44	0.11	0.40	0.52	0.81	0.92	0.25	0.20	-	0.78
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.04%	8.51%	-3.41%	1.86%	11.20%	3.08%	-5.47%	-6.28%	3.41%	-6.20%	14.17%
EBITDA Growth	-25.88%	-13.13%	-64.00%	120.43%	1.14%	73.43%	15.79%	-48.20%	-38.26%	1.73%	99.79%
EBIT Growth	-30.72%	-12.63%	-71.01%	187.47%	-4.51%	54.73%	16.70%	-59.96%	-44.96%	3.13%	201.33%
NOPAT Growth	-30.06%	1.46%	-73.93%	153.36%	26.82%	54.24%	8.19%	-61.78%	-46.31%	8.12%	234.03%
Net Income Growth	-37.41%	-14.30%	-73.67%	258.27%	28.95%	55.46%	11.65%	-75.80%	-18.59%	15.63%	233.84%
EPS Growth	-37.41%	-16.00%	-73.81%	272.73%	21.95%	58.00%	13.92%	-73.33%	-16.67%	15.00%	226.09%
Operating Cash Flow Growth	9.22%	-54.35%	9.29%	100.94%	34.20%	3.02%	-11.20%	-51.09%	-14.21%	78.63%	-2.62%
Free Cash Flow Firm Growth	37.13%	-48.05%	-35.06%	46.22%	45.54%	24.14%	-149.27%	290.43%	-74.81%	157.42%	-3.08%
Invested Capital Growth	-24.36%	33.88%	-13.68%	1.88%	-8.20%	13.09%	166.87%	-17.48%	0.53%	-15.05%	16.00%
Revenue Q/Q Growth	-5.34%	3.89%	-1.18%	1.70%	0.95%	1.39%	-2.04%	-1.82%	1.56%	-2.57%	2.78%
EBITDA Q/Q Growth	-16.75%	9.87%	-28.51%	38.19%	16.20%	7.63%	-0.26%	-28.89%	-6.27%	-14.90%	3.56%
EBIT Q/Q Growth	-19.28%	13.96%	-36.53%	46.54%	17.72%	3.86%	2.31%	-43.26%	48.30%	4.93%	-2.87%
NOPAT Q/Q Growth	-19.39%	40.56%	-55.75%	82.03%	11.04%	-1.26%	9.00%	-48.74%	145.65%	-15.25%	3.45%
Net Income Q/Q Growth	-21.81%	51.40%	-59.40%	101.93%	14.05%	-0.71%	9.17%	-66.96%	401.66%	-18.37%	7.15%
EPS Q/Q Growth	-21.81%	40.00%	-60.71%	105.00%	11.11%	0.00%	11.11%	-65.71%	433.33%	-17.86%	8.70%
Operating Cash Flow Q/Q Growth	21.42%	-42.28%	47.95%	35.81%	9.30%	14.82%	-5.65%	-41.28%	16.82%	-8.83%	-11.53%
Free Cash Flow Firm Q/Q Growth	33.12%	-30.76%	29.81%	27.45%	14.63%	7.27%	-150.76%	383.26%	-88.28%	137.26%	-26.33%
Invested Capital Q/Q Growth	-28.44%	18.83%	-16.76%	-5.37%	-8.75%	-14.18%	105.04%	-12.28%	0.00%	-1.59%	10.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	85.28%	83.57%	83.23%	82.85%	83.19%	83.70%	82.66%	81.54%	79.67%	79.30%	80.37%
EBITDA Margin	8.66%	6.93%	2.58%	5.59%	5.09%	8.56%	10.48%	5.79%	3.46%	3.75%	6.56%
Operating Margin	7.30%	6.49%	2.23%	5.08%	4.34%	6.64%	8.00%	3.67%	2.00%	2.16%	5.34%
EBIT Margin	7.22%	5.81%	1.74%	4.92%	4.23%	6.35%	7.83%	3.35%	1.78%	1.96%	5.17%
Profit (Net Income) Margin	3.74%	2.96%	0.81%	2.84%	3.29%	4.96%	5.86%	1.51%	1.19%	1.47%	4.29%
Tax Burden Percent	66.88%	70.31%	55.26%	60.34%	80.49%	78.77%	74.83%	66.51%	63.52%	67.52%	80.09%
Interest Burden Percent	77.53%	72.34%	83.62%	95.44%	96.62%	99.19%	99.90%	67.93%	105.21%	110.97%	103.65%
Effective Tax Rate	33.12%	29.69%	44.74%	39.66%	19.51%	21.23%	25.17%	33.49%	36.48%	32.48%	19.91%
Return on Invested Capital (ROIC)	88.04%	88.69%	21.68%	58.72%	76.93%	116.33%	64.64%	18.61%	11.02%	12.85%	43.27%
ROIC Less NNEP Spread (ROIC-NNEP)	56.58%	-2.49%	89.93%	64.85%	80.21%	119.54%	66.60%	45.67%	12.96%	12.69%	42.81%
Return on Net Nonoperating Assets (RNNOA)	106.76%	-1.30%	-8.90%	-27.13%	-46.70%	-78.13%	-27.83%	-9.48%	-3.34%	-3.17%	-10.93%
Return on Equity (ROE)	194.81%	87.39%	12.77%	31.59%	30.23%	38.21%	36.81%	9.13%	7.68%	9.69%	32.34%
Cash Return on Invested Capital (CROIC)	115.78%	59.72%	36.36%	56.85%	85.48%	104.05%	-26.33%	37.76%	10.49%	29.13%	28.46%
Operating Return on Assets (OROA)	29.30%	26.49%	7.24%	20.76%	17.95%	25.90%	25.07%	9.24%	5.56%	6.20%	17.86%
Return on Assets (ROA)	15.20%	13.47%	3.35%	11.95%	13.96%	20.23%	18.74%	4.18%	3.71%	4.65%	14.83%
Return on Common Equity (ROCE)	194.81%	87.39%	12.77%	31.59%	30.23%	38.21%	36.81%	9.13%	7.68%	9.69%	32.34%
Return on Equity Simple (ROE_SIMPLE)	214.29%	57.34%	11.07%	26.25%	27.31%	34.73%	35.03%	9.90%	7.33%	11.30%	0.00%
Net Operating Profit after Tax (NOPAT)	9.30	9.43	2.46	6.23	7.90	12	13	5.04	2.71	2.92	9.77
NOPAT Margin	4.88%	4.57%	1.23%	3.07%	3.50%	5.23%	5.99%	2.44%	1.27%	1.46%	4.28%
Net Nonoperating Expense Percent (NNEP)	31.46%	91.18%	-68.25%	-6.13%	-3.29%	-3.21%	-1.96%	-27.06%	-1.93%	0.16%	0.46%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	21.98%
Cost of Revenue to Revenue	14.72%	16.43%	16.77%	17.15%	16.81%	16.30%	17.34%	18.46%	20.33%	20.70%	19.63%
SG&A Expenses to Revenue	30.13%	27.15%	32.54%	29.45%	30.78%	29.16%	27.63%	30.74%	33.30%	34.21%	30.28%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	77.98%	77.08%	81.00%	77.77%	78.85%	77.06%	74.66%	77.87%	77.67%	77.13%	75.03%
Earnings before Interest and Taxes (EBIT)	14	12	3.48	10	9.55	15	17	6.91	3.80	3.92	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	14	5.15	11	11	20	23	12	7.38	7.51	15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	13.80	15.97	3.79	3.71	6.11	5.19	2.50	1.56	1.49	3.14	4.75
Price to Tangible Book Value (P/TBV)	31.74	19.09	4.14	3.90	6.34	5.33	2.55	1.59	1.51	3.18	4.79
Price to Revenue (P/Rev)	0.24	0.82	0.28	0.40	0.74	0.74	0.42	0.24	0.24	0.41	0.72
Price to Earnings (P/E)	6.44	27.84	34.20	14.12	22.36	14.95	7.12	15.78	20.32	27.76	16.79
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.77%	3.10%	7.94%	1.26%
Earnings Yield	15.53%	3.59%	2.92%	7.08%	4.47%	6.69%	14.04%	6.34%	4.92%	3.60%	5.95%
Enterprise Value to Invested Capital (EV/IC)	5.68	14.09	4.85	6.55	15.13	13.54	2.86	1.72	1.69	3.66	6.36
Enterprise Value to Revenue (EV/Rev)	0.27	0.83	0.26	0.34	0.66	0.65	0.38	0.20	0.19	0.38	0.68
Enterprise Value to EBITDA (EV/EBITDA)	3.14	11.98	9.89	6.17	12.95	7.56	3.67	3.53	5.63	10.18	10.28
Enterprise Value to EBIT (EV/EBIT)	3.76	14.29	14.65	7.01	15.57	10.19	4.91	6.11	10.94	19.50	13.06
Enterprise Value to NOPAT (EV/NOPAT)	5.56	18.19	20.74	11.25	18.83	12.36	6.43	8.38	15.37	26.14	15.79
Enterprise Value to Operating Cash Flow (EV/OCF)	3.91	28.42	7.73	5.29	8.36	8.22	5.21	5.30	6.09	6.27	12.99
Enterprise Value to Free Cash Flow (EV/FCFF)	4.23	27.01	12.36	11.62	16.95	13.82	0.00	4.13	16.14	11.53	24.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.92	0.88	0.51	0.25	0.05	0.00	0.44	0.42	0.33	0.45	0.28
Long-Term Debt to Equity	2.57	0.70	0.37	0.16	0.00	0.00	0.44	0.42	0.33	0.45	0.28
Financial Leverage	1.89	0.52	-0.10	-0.42	-0.58	-0.65	-0.42	-0.21	-0.26	-0.25	-0.26
Leverage Ratio	12.82	6.49	3.82	2.64	2.17	1.89	1.96	2.19	2.07	2.08	2.18
Compound Leverage Factor	9.94	4.69	3.19	2.52	2.09	1.87	1.96	1.49	2.18	2.31	2.26
Debt to Total Capital	85.54%	46.91%	33.87%	19.78%	5.07%	0.00%	30.34%	29.45%	25.03%	31.23%	22.07%
Short-Term Debt to Total Capital	48.44%	9.97%	9.10%	7.31%	5.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	37.10%	36.94%	24.76%	12.47%	0.00%	0.00%	30.34%	29.45%	25.03%	31.23%	22.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	14.46%	53.09%	66.13%	80.22%	94.93%	100.00%	69.66%	70.55%	74.97%	68.77%	77.93%
Debt to EBITDA	1.19	0.66	1.44	0.48	0.13	0.00	0.69	1.10	1.57	1.57	0.65
Net Debt to EBITDA	0.35	0.11	-0.78	-0.99	-1.51	0.00	-0.31	-0.59	-1.36	-0.68	-0.69
Long-Term Debt to EBITDA	0.52	0.52	1.06	0.30	0.00	0.00	0.69	1.10	1.57	1.57	0.65
Debt to NOPAT	2.12	1.00	3.03	0.87	0.18	0.00	1.22	2.61	4.28	4.03	1.00
Net Debt to NOPAT	0.62	0.16	-1.63	-1.80	-2.20	0.00	-0.54	-1.40	-3.71	-1.74	-1.06
Long-Term Debt to NOPAT	0.92	0.79	2.21	0.55	0.00	0.00	1.22	2.61	4.28	4.03	1.00
Altman Z-Score	2.80	4.68	2.75	3.83	6.05	6.99	3.54	2.41	2.77	2.74	4.73
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.18	1.41	1.52	1.64	1.65	1.75	1.91	1.83	2.26	1.69	1.87
Quick Ratio	0.58	0.31	0.55	0.79	0.80	0.99	1.04	0.91	1.18	0.89	0.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	12	6.35	4.12	6.03	8.78	11	-5.37	10	2.58	6.63	6.42
Operating Cash Flow to CapEx	1,140.72%	1,074.02%	625.31%	285.14%	709.86%	683.55%	435.81%	520.20%	223.21%	543.30%	868.91%
Free Cash Flow to Firm to Interest Expense	3.96	1.91	7.24	13.23	27.17	90.80	-315.79	1,022.32	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	4.28	1.82	11.57	29.07	55.07	152.72	957.24	795.90	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	3.91	1.65	9.72	18.88	47.32	130.38	737.59	642.90	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	4.06	4.56	4.15	4.22	4.25	4.08	3.20	2.76	3.12	3.17	3.46
Accounts Receivable Turnover	162.13	159.92	138.25	119.50	109.34	99.62	79.56	65.90	86.22	87.77	73.21
Inventory Turnover	3.10	1.97	1.61	2.31	2.77	2.75	2.54	2.34	2.67	2.66	2.51
Fixed Asset Turnover	29.97	44.83	60.61	41.84	32.94	32.57	24.07	20.01	22.96	23.69	32.60
Accounts Payable Turnover	10.25	5.90	4.87	8.05	8.45	8.73	7.44	5.36	7.91	8.86	8.58
Days Sales Outstanding (DSO)	2.25	2.28	2.64	3.05	3.34	3.66	4.59	5.54	4.23	4.16	4.99
Days Inventory Outstanding (DIO)	117.76	184.82	227.42	158.17	131.59	132.88	143.53	156.25	136.90	137.09	145.32
Days Payable Outstanding (DPO)	35.63	61.88	74.96	45.37	43.22	41.83	49.06	68.05	46.13	41.21	42.52
Cash Conversion Cycle (CCC)	84.39	125.23	155.11	115.85	91.71	94.71	99.06	93.74	95.00	100.03	107.78
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9.09	12	11	11	9.83	11	30	24	25	21	24
Invested Capital Turnover	18.03	19.42	17.59	19.16	22.01	22.24	10.80	7.62	8.69	8.80	10.12
Increase / (Decrease) in Invested Capital	-2.93	3.08	-1.67	0.20	-0.88	1.29	19	-5.19	0.13	-3.70	3.35
Enterprise Value (EV)	52	172	51	70	149	151	85	42	42	76	154
Market Capitalization	46	170	55	81	166	173	92	49	52	82	165
Book Value per Share	$0.03	$0.76	$1.02	$1.53	$1.90	$2.32	$2.63	$2.50	$2.71	$2.05	$2.75
Tangible Book Value per Share	$0.01	$0.64	$0.93	$1.46	$1.83	$2.26	$2.58	$2.46	$2.67	$2.02	$2.73
Total Capital	23	20	22	27	29	33	53	45	46	38	44
Total Debt	20	9.41	7.44	5.41	1.45	0.00	16	13	12	12	9.81
Total Long-Term Debt	8.53	7.41	5.44	3.41	0.00	0.00	16	13	12	12	9.81
Net Debt	5.77	1.53	-4.02	-11	-17	-22	-7.14	-7.04	-10	-5.09	-10
Capital Expenditures (CapEx)	1.16	0.56	1.06	4.65	2.51	2.68	3.73	1.53	3.06	2.25	1.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.85	6.60	2.73	0.48	-0.38	-3.29	-0.32	1.04	3.07	-1.55	3.48
Debt-free Net Working Capital (DFNWC)	16	14	14	17	18	19	23	21	25	15	24
Net Working Capital (NWC)	4.62	12	12	15	17	19	23	21	25	15	24
Net Nonoperating Expense (NNE)	2.17	3.33	0.85	0.47	0.47	0.63	0.29	1.92	0.17	-0.01	-0.04
Net Nonoperating Obligations (NNO)	5.77	1.53	-4.02	-11	-17	-22	-7.14	-7.04	-10	-5.09	-10
Total Depreciation and Amortization (D&A)	2.74	2.31	1.67	1.36	1.94	5.15	5.83	5.05	3.58	3.59	3.19
Debt-free, Cash-free Net Working Capital to Revenue	0.97%	3.20%	1.37%	0.24%	-0.17%	-1.41%	-0.14%	0.50%	1.44%	-0.77%	1.52%
Debt-free Net Working Capital to Revenue	8.28%	7.01%	7.11%	8.43%	8.16%	8.09%	10.38%	10.29%	11.56%	7.66%	10.36%
Net Working Capital to Revenue	2.42%	6.04%	6.11%	7.45%	7.52%	8.09%	10.38%	10.29%	11.56%	7.66%	10.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.49	$0.44	$0.12	$0.41	$0.53	$0.82	$0.92	$0.24	$0.20	$0.24	$0.80
Adjusted Weighted Average Basic Shares Outstanding	13.90M	13.73M	13.88M	13.99M	14.06M	14.11M	14.07M	12.89M	12.56M	12.46M	12.25M
Adjusted Diluted Earnings per Share	$0.49	$0.41	$0.11	$0.41	$0.50	$0.79	$0.90	$0.24	$0.20	$0.23	$0.75
Adjusted Weighted Average Diluted Shares Outstanding	13.93M	14.53M	14.23M	14.09M	14.12M	14.35M	13.65M	13.07M	12.57M	12.99M	12.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.93M	14.53M	14.23M	14.09M	14.12M	14.35M	13.65M	12.55M	12.70M	12.48M	12.69M
Normalized Net Operating Profit after Tax (NOPAT)	9.30	9.43	2.46	6.23	7.90	12	13	5.04	2.71	2.92	9.77
Normalized NOPAT Margin	4.88%	4.57%	1.23%	3.07%	3.50%	5.23%	5.99%	2.44%	1.27%	1.46%	4.28%
Pre Tax Income Margin	5.60%	4.20%	1.46%	4.70%	4.08%	6.29%	7.83%	2.27%	1.87%	2.17%	5.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.45	3.61	6.11	21.94	29.58	123.18	1,014.65	690.60	0.00	0.00	0.00
NOPAT to Interest Expense	3.01	2.84	4.31	13.66	24.46	101.53	775.33	503.82	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	4.08	3.45	4.25	11.74	21.82	100.83	795.00	537.60	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	2.64	2.67	2.46	3.46	16.70	79.18	555.68	350.82	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.12%	62.44%	236.30%	21.08%
Augmented Payout Ratio	138.25%	0.00%	0.00%	26.04%	62.66%	46.80%	92.55%	295.22%	94.80%	455.23%	53.18%

This table displays calculated financial ratios and metrics derived from Lifevantage's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	12,701,736.00	12,713,887.00	12,868,462.00	-	-	-	12,551,281.00	12,588,183.00	12,691,009.00	12,701,187.00	12,793,359.00
DEI Adjusted Shares Outstanding	12,701,736.00	12,713,887.00	12,868,462.00	-	-	-	12,551,281.00	12,588,183.00	12,691,009.00	12,701,187.00	12,793,359.00
DEI Earnings Per Adjusted Shares Outstanding	0.05	-0.05	0.13	-	-	-	0.28	0.16	0.17	0.02	0.11
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.79%	-3.80%	-10.23%	-9.76%	-8.08%	31.26%	21.13%	12.64%	0.74%	-27.79%	-25.20%
EBITDA Growth	-2.23%	-198.96%	23.19%	20.68%	104.85%	821.52%	32.79%	20.42%	-24.61%	-44.27%	-65.74%
EBIT Growth	-22.42%	-10.21%	14.88%	7.51%	281.09%	342.54%	119.46%	-13.25%	-14.49%	-84.69%	-59.69%
NOPAT Growth	-38.47%	-2.35%	70.17%	-30.01%	220.31%	420.59%	101.44%	25.42%	19.81%	-89.96%	-58.98%
Net Income Growth	3.11%	38.00%	62.33%	-33.62%	190.30%	488.72%	109.16%	50.11%	18.02%	-89.18%	-60.75%
EPS Growth	0.00%	37.50%	62.50%	-33.33%	180.00%	480.00%	100.00%	60.00%	21.43%	-89.47%	-57.69%
Operating Cash Flow Growth	454.28%	81.70%	-10.17%	-31.38%	-112.24%	423.56%	-27.97%	-59.95%	-295.37%	-69.66%	123.88%
Free Cash Flow Firm Growth	138.21%	-174.21%	-167.76%	172.87%	-85.42%	163.47%	113.50%	-131.13%	-536.31%	-310.78%	-320.70%
Invested Capital Growth	-13.24%	58.91%	0.00%	-15.05%	5.22%	-13.26%	3.40%	16.00%	19.58%	64.81%	32.82%
Revenue Q/Q Growth	-5.27%	0.51%	-6.55%	1.42%	-3.51%	43.52%	-13.76%	-5.69%	-13.70%	2.88%	-10.66%
EBITDA Q/Q Growth	-14.28%	-126.41%	872.15%	-18.09%	45.51%	-6.99%	42.11%	-37.39%	-8.91%	-31.24%	-12.64%
EBIT Q/Q Growth	-73.02%	-284.57%	251.23%	42.76%	-4.37%	17.47%	36.84%	-43.57%	-5.73%	-78.97%	260.26%
NOPAT Q/Q Growth	-71.59%	-255.32%	289.22%	-16.16%	30.00%	55.46%	18.90%	-47.80%	24.18%	-86.97%	385.66%
Net Income Q/Q Growth	-68.01%	-204.29%	352.90%	-21.34%	39.92%	39.65%	36.08%	-43.54%	10.01%	-87.19%	393.48%
EPS Q/Q Growth	-66.67%	-200.00%	360.00%	-23.08%	40.00%	35.71%	36.84%	-38.46%	6.25%	-88.24%	450.00%
Operating Cash Flow Q/Q Growth	26.63%	-63.13%	76.04%	-16.52%	-122.58%	1,677.87%	-75.78%	-53.59%	-322.92%	221.08%	78.72%
Free Cash Flow Firm Q/Q Growth	120.91%	-319.70%	-115.60%	126.08%	-88.20%	856.59%	-54.15%	-160.14%	-65.41%	-362.13%	52.00%
Invested Capital Q/Q Growth	-5.12%	-5.31%	-3.91%	-1.59%	17.51%	-21.94%	14.55%	10.40%	21.13%	7.59%	-7.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	80.18%	78.56%	78.92%	79.52%	79.90%	80.53%	80.98%	79.92%	79.51%	74.00%	79.02%
EBITDA Margin	3.49%	-0.92%	7.59%	5.16%	7.79%	5.05%	8.32%	5.52%	5.83%	3.90%	3.81%
Operating Margin	1.46%	-2.44%	4.01%	5.95%	5.44%	5.06%	6.94%	3.90%	4.77%	1.00%	3.84%
EBIT Margin	1.29%	-2.36%	3.82%	5.38%	5.34%	4.37%	6.93%	4.15%	4.53%	0.93%	3.73%
Profit (Net Income) Margin	1.22%	-1.27%	3.44%	2.67%	3.87%	3.76%	5.94%	3.55%	4.53%	0.56%	3.12%
Tax Burden Percent	75.87%	58.99%	86.36%	48.12%	70.83%	82.55%	83.01%	81.76%	96.16%	58.35%	82.25%
Interest Burden Percent	125.42%	91.15%	104.12%	102.96%	102.34%	104.39%	103.24%	104.86%	104.04%	104.42%	101.47%
Effective Tax Rate	24.13%	0.00%	13.64%	51.88%	29.17%	17.45%	16.99%	18.24%	3.84%	41.65%	17.75%
Return on Invested Capital (ROIC)	9.38%	-20.03%	66.96%	25.17%	31.54%	42.92%	59.25%	32.25%	38.91%	4.80%	24.11%
ROIC Less NNEP Spread (ROIC-NNEP)	8.27%	-21.86%	67.37%	26.43%	31.42%	46.44%	58.05%	29.63%	39.66%	4.94%	24.34%
Return on Net Nonoperating Assets (RNNOA)	-1.48%	8.90%	-13.90%	-6.59%	-5.00%	-12.92%	-16.78%	-7.56%	-4.50%	-0.95%	-5.86%
Return on Equity (ROE)	7.90%	-11.13%	53.06%	18.58%	26.54%	30.00%	42.47%	24.69%	34.41%	3.85%	18.26%
Cash Return on Invested Capital (CROIC)	23.70%	-30.11%	-167.51%	29.13%	12.32%	51.63%	40.36%	28.46%	19.71%	-19.11%	-6.32%
Operating Return on Assets (OROA)	4.08%	-7.68%	12.82%	17.05%	16.33%	14.12%	22.24%	14.33%	16.85%	3.00%	10.46%
Return on Assets (ROA)	3.89%	-4.13%	11.52%	8.45%	11.84%	12.17%	19.06%	12.28%	16.86%	1.83%	8.73%
Return on Common Equity (ROCE)	7.90%	-11.13%	53.06%	18.58%	26.54%	30.00%	42.47%	24.69%	34.41%	3.85%	18.26%
Return on Equity Simple (ROE_SIMPLE)	8.74%	10.84%	13.44%	0.00%	14.93%	24.56%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	0.57	-0.88	1.67	1.40	1.82	2.83	3.36	1.76	2.18	0.28	1.38
NOPAT Margin	1.11%	-1.71%	3.46%	2.86%	3.86%	4.18%	5.76%	3.19%	4.59%	0.58%	3.16%
Net Nonoperating Expense Percent (NNEP)	1.11%	1.83%	-0.41%	-1.26%	0.12%	-3.52%	1.20%	2.62%	-0.75%	-0.14%	-0.22%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.24%	4.32%	-	-	6.94%	7.57%	3.95%	5.14%	0.68%	3.31%
Cost of Revenue to Revenue	19.82%	21.44%	21.08%	20.48%	20.10%	19.47%	19.02%	20.08%	20.49%	26.00%	20.98%
SG&A Expenses to Revenue	34.97%	38.87%	34.05%	28.65%	31.45%	27.47%	29.20%	33.89%	31.23%	32.35%	31.72%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	78.72%	81.01%	74.91%	73.57%	74.45%	75.47%	74.05%	76.03%	74.74%	73.00%	75.18%
Earnings before Interest and Taxes (EBIT)	0.66	-1.22	1.85	2.63	2.52	2.96	4.05	2.29	2.15	0.45	1.63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.80	-0.47	3.66	2.53	3.68	3.42	4.86	3.04	2.77	1.91	1.67
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.74	2.75	2.87	3.14	5.44	7.35	5.26	4.75	3.72	2.37	1.66
Price to Tangible Book Value (P/TBV)	2.78	2.79	2.91	3.18	5.50	7.41	5.29	4.79	3.75	2.68	1.86
Price to Revenue (P/Rev)	0.38	0.36	0.37	0.41	0.77	1.04	0.80	0.72	0.54	0.37	0.28
Price to Earnings (P/E)	31.38	25.33	21.33	27.76	36.47	29.91	19.53	16.79	12.19	9.95	9.61
Dividend Yield	7.83%	8.48%	8.47%	7.94%	1.24%	0.88%	1.12%	1.26%	1.75%	2.84%	4.17%
Earnings Yield	3.19%	3.95%	4.69%	3.60%	2.74%	3.34%	5.12%	5.95%	8.21%	10.05%	10.41%
Enterprise Value to Invested Capital (EV/IC)	3.19	3.16	3.35	3.66	6.01	10.89	7.59	6.36	4.07	2.43	1.75
Enterprise Value to Revenue (EV/Rev)	0.35	0.33	0.35	0.38	0.75	0.98	0.75	0.68	0.52	0.37	0.26
Enterprise Value to EBITDA (EV/EBITDA)	10.13	10.93	10.07	10.18	15.72	15.72	11.51	10.28	8.49	6.11	5.44
Enterprise Value to EBIT (EV/EBIT)	20.60	19.96	19.06	19.50	25.55	20.98	13.71	13.06	10.46	8.60	7.83
Enterprise Value to NOPAT (EV/NOPAT)	31.08	25.17	20.63	26.14	35.40	27.03	17.65	15.79	11.82	10.14	9.13
Enterprise Value to Operating Cash Flow (EV/OCF)	5.75	5.08	5.32	6.27	21.55	14.61	12.42	12.99	11.79	20.51	7.85
Enterprise Value to Free Cash Flow (EV/FCFF)	12.48	0.00	0.00	11.53	50.00	19.60	19.11	24.01	22.51	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.43	0.44	0.44	0.45	0.41	0.36	0.31	0.28	0.28	0.27	0.25
Long-Term Debt to Equity	0.43	0.44	0.44	0.45	0.41	0.36	0.31	0.28	0.28	0.27	0.25
Financial Leverage	-0.18	-0.41	-0.21	-0.25	-0.16	-0.28	-0.29	-0.26	-0.11	-0.19	-0.24
Leverage Ratio	2.19	2.14	2.29	2.08	2.25	2.29	2.28	2.18	2.02	2.06	2.07
Compound Leverage Factor	2.75	1.95	2.38	2.15	2.30	2.39	2.35	2.29	2.10	2.15	2.10
Debt to Total Capital	29.84%	30.76%	30.69%	31.23%	29.28%	26.69%	23.46%	22.07%	21.92%	21.06%	19.97%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	29.84%	30.76%	30.69%	31.23%	29.28%	26.69%	23.46%	22.07%	21.92%	21.06%	19.97%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	70.16%	69.24%	69.31%	68.77%	70.72%	73.31%	76.54%	77.93%	78.08%	78.94%	80.03%
Debt to EBITDA	1.70	1.90	1.68	1.57	1.22	0.82	0.72	0.65	0.66	0.70	0.89
Net Debt to EBITDA	-0.81	-0.81	-0.78	-0.68	-0.33	-0.81	-0.83	-0.69	-0.27	-0.11	-0.44
Long-Term Debt to EBITDA	1.70	1.90	1.68	1.57	1.22	0.82	0.72	0.65	0.66	0.70	0.89
Debt to NOPAT	5.21	4.38	3.43	4.03	2.75	1.41	1.10	1.00	0.92	1.16	1.49
Net Debt to NOPAT	-2.48	-1.87	-1.60	-1.74	-0.75	-1.39	-1.28	-1.06	-0.37	-0.18	-0.74
Long-Term Debt to NOPAT	5.21	4.38	3.43	4.03	2.75	1.41	1.10	1.00	0.92	1.16	1.49
Altman Z-Score	2.65	2.48	2.62	2.67	3.86	4.79	3.99	4.30	4.61	3.14	2.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.70	1.68	1.68	1.69	1.76	1.66	1.66	1.87	2.39	2.03	1.96
Quick Ratio	0.85	0.85	0.87	0.89	0.80	0.86	0.79	0.86	0.82	0.65	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4.13	-9.08	-20	5.10	0.60	5.76	2.64	-1.59	-2.63	-12	-5.83
Operating Cash Flow to CapEx	420.56%	323.57%	1,062.89%	928.78%	-168.99%	1,869.72%	673.11%	519.60%	-525.06%	257.47%	493.37%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	3.17	3.25	3.35	3.17	3.06	3.23	3.21	3.46	3.72	3.24	2.80
Accounts Receivable Turnover	96.37	90.00	96.23	87.77	71.64	95.95	82.73	73.21	84.88	96.73	69.02
Inventory Turnover	2.54	2.57	2.80	2.66	2.50	2.64	2.34	2.51	2.41	2.45	2.10
Fixed Asset Turnover	22.76	22.90	24.61	23.69	23.35	26.34	29.49	32.60	33.97	30.98	28.77
Accounts Payable Turnover	5.97	7.12	6.11	8.86	6.77	7.15	6.26	8.58	9.37	8.39	7.01
Days Sales Outstanding (DSO)	3.79	4.06	3.79	4.16	5.09	3.80	4.41	4.99	4.30	3.77	5.29
Days Inventory Outstanding (DIO)	143.67	142.08	130.25	137.09	146.09	138.06	155.69	145.32	151.72	148.98	173.52
Days Payable Outstanding (DPO)	61.12	51.26	59.74	41.21	53.89	51.05	58.27	42.52	38.94	43.53	52.07
Cash Conversion Cycle (CCC)	86.34	94.87	74.31	100.03	97.29	90.82	101.83	107.78	117.08	109.23	126.74
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	23	22	21	21	25	19	22	24	29	32	29
Invested Capital Turnover	8.48	11.71	19.34	8.80	8.18	10.28	10.29	10.12	8.49	8.27	7.64
Increase / (Decrease) in Invested Capital	-3.56	8.20	21	-3.70	1.22	-2.93	0.72	3.35	4.81	12	7.21
Enterprise Value (EV)	74	70	71	76	148	209	167	154	120	77	51
Market Capitalization	80	75	77	82	151	220	179	165	123	78	55
Book Value per Share	$2.31	$2.15	$2.08	$2.05	$2.22	$2.39	$2.71	$2.75	$2.61	$2.60	$2.61
Tangible Book Value per Share	$2.27	$2.12	$2.05	$2.02	$2.20	$2.37	$2.69	$2.73	$2.59	$2.30	$2.32
Total Capital	42	39	39	38	39	41	44	44	42	42	42
Total Debt	12	12	12	12	11	11	10	9.81	9.31	8.80	8.32
Total Long-Term Debt	12	12	12	12	11	11	10	9.81	9.31	8.80	8.32
Net Debt	-5.95	-5.20	-5.53	-5.09	-3.13	-11	-12	-10	-3.78	-1.38	-4.16
Capital Expenditures (CapEx)	1.13	0.54	0.29	0.28	0.35	0.49	0.33	0.20	0.44	1.08	1.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.20	-1.69	-2.06	-1.55	2.15	-3.35	-0.94	3.48	13	9.36	6.73
Debt-free Net Working Capital (DFNWC)	17	16	15	15	17	18	22	24	26	20	19
Net Working Capital (NWC)	17	16	15	15	17	18	22	24	26	20	19
Net Nonoperating Expense (NNE)	-0.06	-0.23	0.01	0.10	-0.01	0.28	-0.11	-0.20	0.03	0.01	0.02
Net Nonoperating Obligations (NNO)	-5.95	-5.20	-5.53	-5.09	-3.13	-11	-12	-10	-3.78	-1.38	-4.16
Total Depreciation and Amortization (D&A)	1.13	0.75	1.82	-0.11	1.16	0.46	0.81	0.76	0.62	1.45	0.03
Debt-free, Cash-free Net Working Capital to Revenue	-0.56%	-0.80%	-1.00%	-0.77%	1.10%	-1.58%	-0.42%	1.52%	5.74%	4.46%	3.45%
Debt-free Net Working Capital to Revenue	8.08%	7.42%	7.46%	7.66%	8.54%	8.60%	9.68%	10.36%	11.46%	9.30%	9.84%
Net Working Capital to Revenue	8.08%	7.42%	7.46%	7.66%	8.54%	8.60%	9.68%	10.36%	11.46%	9.30%	9.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.05	($0.05)	$0.13	$0.11	$0.15	$0.21	$0.28	$0.16	$0.17	$0.02	$0.11
Adjusted Weighted Average Basic Shares Outstanding	12.54M	12.61M	12.42M	12.46M	12.16M	12.21M	12.35M	12.25M	12.40M	12.64M	12.63M
Adjusted Diluted Earnings per Share	$0.05	($0.05)	$0.13	$0.10	$0.14	$0.19	$0.26	$0.16	$0.17	$0.02	$0.11
Adjusted Weighted Average Diluted Shares Outstanding	13.11M	12.61M	12.99M	12.99M	12.82M	13.18M	13.30M	12.99M	12.95M	12.75M	12.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.71M	12.87M	12.70M	12.48M	12.53M	12.55M	12.59M	12.69M	12.70M	12.79M	12.62M
Normalized Net Operating Profit after Tax (NOPAT)	0.57	-0.88	1.67	2.04	1.82	2.83	3.36	1.76	2.18	0.28	1.38
Normalized NOPAT Margin	1.11%	-1.71%	3.46%	4.16%	3.86%	4.18%	5.76%	3.19%	4.59%	0.58%	3.16%
Pre Tax Income Margin	1.61%	-2.15%	3.98%	5.54%	5.46%	4.56%	7.15%	4.35%	4.71%	0.97%	3.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	263.50%	230.23%	191.27%	236.30%	46.11%	26.61%	21.94%	21.08%	21.10%	28.13%	39.66%
Augmented Payout Ratio	326.69%	348.19%	341.94%	455.23%	209.36%	93.00%	54.13%	53.18%	46.86%	61.34%	102.52%

Financials Breakdown Chart

Key Financial Trends

Lifevantage (NASDAQ: LFVN) is showing a mixed but improving operating profile in the most recent quarter, with stronger profitability and solid operating cash flow, though revenue remains below last year’s levels.

In Q3 2026, Lifevantage generated $43.7 million in revenue, down from $58.4 million in the same quarter last year. Even so, the company produced $1.36 million in net income and $4.99 million in operating cash flow, which suggests the business is still converting sales into cash despite softer top-line growth.

Operating cash flow was strong in Q3 2026 at $5.0 million, up from $2.2 million in Q3 2025, showing better cash generation from the business.
Net income improved sequentially to $1.36 million in Q3 2026 from $0.28 million in Q2 2026, indicating better bottom-line performance.
Gross profit remained healthy at $34.5 million, reflecting solid underlying product margins.
Cash on hand increased to $12.5 million from $10.2 million in Q2 2026, helped by positive quarterly cash generation.
Inventory declined modestly to $18.4 million from $19.0 million in Q2 2026, which can be a sign of improving working-capital discipline.
Revenue recovered from Q2 2026, rising from $48.9 million to $43.7 million? Actually, Q3 was lower than Q2, so the bigger takeaway is that revenue remains volatile quarter to quarter and below prior-year levels.
SG&A fell to $13.9 million from $15.8 million in Q2 2026, helping support profitability.
Capital spending stayed modest at about $1.0 million, which limits near-term cash outflows.
Revenue declined year over year from $58.4 million in Q3 2025 to $43.7 million in Q3 2026, a meaningful drop that signals weaker demand or a smaller sales base.
Other operating expenses remain elevated at $19.0 million, continuing to absorb a large share of gross profit.

Looking at the broader trend over the last four quarters, Lifevantage has moved from a very strong Q2 2025, when operating cash flow reached $9.2 million, to a much softer Q1 2026, which posted negative operating cash flow of $2.3 million. The latest quarter is a rebound from that weakness, but the company’s cash generation remains uneven.

The balance sheet also looks somewhat more constrained than it did a year ago. Total assets were $62.1 million in Q3 2026 versus $77.2 million in Q3 2025, while liabilities fell to $28.8 million from $43.2 million. Equity improved to $33.3 million, but retained earnings remain deeply negative at -$103.7 million, which reflects years of accumulated losses.

Bottom line: Lifevantage is still profitable and generating cash, which is encouraging for a small-cap consumer company. However, investors should keep an eye on the declining year-over-year revenue trend and the company’s reliance on cost control and working-capital improvements to maintain earnings momentum.

07/17/26 01:04 AM ETAI Generated. May Contain Errors.

Lifevantage Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lifevantage's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

In the past 10 years, Lifevantage's net income has ranged from $1.61 million in 2017 to $12.89 million in 2021, and is currently $9.81 million as of their latest financial filing in 2025. Check out Lifevantage's forecast to explore projected trends and price targets.

Lifevantage's total operating income in 2025 was $12.20 million, based on the following breakdown:

Total Gross Profit: $183.67 million
Total Operating Expenses: $171.47 million

Over the last 10 years, Lifevantage's total revenue changed from $190.34 million in 2015 to $228.53 million in 2025, a change of 20.1%.

Lifevantage's total liabilities were at $37.32 million at the end of 2025, a 8.8% increase from 2024, and a 2.4% increase since 2015.

In the past 10 years, Lifevantage's cash and equivalents has ranged from $7.88 million in 2016 to $23.17 million in 2021, and is currently $20.20 million as of their latest financial filing in 2025.

Over the last 10 years, Lifevantage's book value per share changed from 0.03 in 2015 to 2.75 in 2025, a change of 7,923.0%.

Related Companies

Financial statements for NASDAQ:LFVN last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifevantage (LFVN) Financials

Financials Breakdown Chart

Key Financial Trends

Lifevantage Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifevantage (LFVN) Financials

Annual Income Statements for Lifevantage

Quarterly Income Statements for Lifevantage

Annual Cash Flow Statements for Lifevantage

Quarterly Cash Flow Statements for Lifevantage

Annual Balance Sheets for Lifevantage

Quarterly Balance Sheets for Lifevantage

Annual Metrics And Ratios for Lifevantage

Quarterly Metrics And Ratios for Lifevantage

Financials Breakdown Chart

Key Financial Trends

Lifevantage Financials - Frequently Asked Questions

When does Lifevantage's financial year end?

How has Lifevantage's net income changed over the last 10 years?

What is Lifevantage's operating income?

How has Lifevantage's revenue changed over the last 10 years?

How much debt does Lifevantage have?

How much cash does Lifevantage have?

How has Lifevantage's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools